Founder, VitalDecades
90 guides published
Mario Bailey founded VitalDecades and answers for every guide on it. He is a software engineer with more than a decade of experience building secure, reliable systems, and a U.S. Air Force veteran. He runs the site's data pipelines and its source checks: each number is read against the guideline, label or public record that sets it, and that source's date is printed beside it.
He is not a clinician, and no named clinician reviews this site yet. How pages are checked sets out what the checks cover and what they do not.
Yes. The FDA approved Zepbound (tirzepatide) on December 20, 2024 to treat moderate to severe obstructive sleep apnea …
Yes, for one stage of the disease. The FDA approved Wegovy injection on August 15, 2025 for adults …
A first PSA between 4 and 10 ng/mL should be followed by a second PSA, not a biopsy: …
Not under the four US rules quoted here: the USPSTF, the American Cancer Society and Medicare all start …
There is no exact conversion: multiplying Lp(a) in mg/dL by 2 to 2.5 gives an estimate in nmol/L, …
As a single test, no. In the trials the FDA reviewed, Cologuard detected 92.3% to 95.3% of the …
Under the USPSTF's 2021 recommendation, annual lung cancer screening stops once you have gone 15 years without smoking, …
The American Thyroid Association's guidelines name no TSH level that is an emergency on its own. The threshold …
The AACE and ATA thyroid guidelines set no TSH level that counts as an emergency on its own. …
No major US guideline tells women 75 and older to stop having mammograms, and none tells every woman …
Usually yes for the medication, and only conditionally for the program. IRS Publication 502 counts amounts paid for …
In the two commercial insurers' policies we read, Cigna's and UnitedHealthcare's, plans that cover weight-loss drugs approve Wegovy …
We are not sending the newsletter yet. Leave your address and you will get the first one when we turn sending on, and nothing before it. Every number sourced and dated. Free, no spam.
We'll never share your email. We never sell your data.